Grünenthal Clinical Trial Portal

As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available. Please consult the table below to easily find information on Grünenthal sponsored clinical trials.

Number Product Condition Brief Title Column Phase Status Results
No
AV001 Neuropathic pain Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery (RISE) 3 Ongoing No
AV002 Painful Diabetic Peripheral Neuropathy Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy 4 Ongoing No
HP7040-01 Treatment of pain A randomized, single-center, double-blind, placebo-controlled, first-in-human trial with single and multiple ascending doses to determine safety, tolerability, and pharmacokinetics of GRT7040 in healthy volunteers 1 Ongoing No
HP6019-01 Inflammatory and autoimmune diseases A randomized, single-center, double-blind, placebo-controlled, first-inhuman trial with single ascending doses to determine safety, tolerability, and pharmacokinetics of GRT6019 in healthy male subjects 1 Completed No
HP6019-02 Inflammatory and autoimmune diseases A randomized, double-blind, placebo controlled, multiple ascending dose trial of GRT6019 in healthy male subjects to evaluate safety, tolerability, and pharmacokinetics of multiple doses of GRT6019 1 Completed No
KF7039-01 Osteoarthritis Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis 3 Completed No
KF7039-02 Osteoarthritis Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee 3 Completed No
KF7039-03 Osteoarthritis Open-label trial to check the safety and tolerability of RTX-GRT7039 injections for pain associated with osteoarthritis of the knee 3 Completed No
KF10004/01 5% Lidocaine medicated plaster Postherpetic neuralgia 3 Completed No